Abiopharma

Clinical trial NCT06741969: completion date: 2029-08-02 → 2029-05-18.

Clinical trial NCT07267026 updates: 1. completion date: 2026-08-31 → 2026-10-04 2. primary completion date: 2026-08-31 → 2026-10-04

Clinical trial NCT04860635 updates: 1. start date: 2026-09-01 → 2027-01-01 2. completion date: 2028-04-01 → 2028-07-01 3. primary completion date: 2028-04-01 → 2028-07-01

Clinical trial NCT05723055 updates: 1. completion date: 2028-04-01 → 2028-11-01 2. primary completion date: 2026-05-01 → 2026-12-01

Clinical trial NCT07148414: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06500884 updates: 1. completion date: 2029-04-30 → 2030-05-30 2. primary completion date: 2026-04-15 → 2030-05-30

Clinical trial NCT05765084 updates: 1. completion date: 2026-10-01 → 2027-10-01 2. primary completion date: 2026-10-01 → 2027-10-01

Clinical trial NCT06878404: primary completion date: 2026-05-27 → 2026-07-24.

Clinical trial NCT04557059 updates: 1. completion date: 2029-08-27 → 2031-09-15 2. enrollment: 693 → 692 participants

Clinical trial NCT04748419 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-03-01 → 2025-09-26 3. primary completion date: 2026-03-01 → 2025-09-26